‘India’s COVID-19 story is the story of Atmanirbharta, who saved millions of lives, the self-confidence that we can fight the coronavirus, and Prime Minister Narendra Modi’s signature leadership. Our story is the story of India’s resilient public health system and everyone working together as Team India to fight the pandemic,’ said Dr VK Paul, Member (Health), NITI Aayog. Dr Paul was speaking at NITI Aayog’s first in-house lecture series on India’s development strategies.
NITI’s flagship in-house lecture series aims to make participants aware of key initiatives and practices of the government, inculcate shared commitments, create a more productive and inclusive environment and foster innovative thinking to meet the developmental objectives of the nation. have to give.
Delivering the inaugural lecture, ‘Covid-19 Vaccination: The India Story’, Dr Paul traveled to India by July 2022 to reach audiences of 2 billion doses. Dr Paul talked about the enabling structures and developments set up by NITI since 2020. Various vaccines and their effects, and India’s Vaccine Friendship Program.
Dr. VK Paul after today’s lecture; Rajesh Bhushan, Secretary (Health); Dr. Krishna Ella, Founder, Bharat Biotech; and Priyam Gandhi-Modi, author and political strategist, moderated by Param Iyer, CEO of NITI Aayog.
In her concluding remarks, NITI Aayog Vice-Chairman Suman Berry said, “Our vaccination campaign as envisioned by the Prime Minister reflects what India can achieve when the people of India come together in the spirit of public participation. The global community sees India as a role model because of an effective immunization program based on the “Vasudhaiv Kutumbakam” ideology.
India Development Strategy Lecture Series will be held every month. The lectures will focus on national development priorities, policies for inclusive growth, best practices in various sectors, initiatives to promote cooperative and competitive federalism.
Today’s lecture was attended by over 300 people including senior leadership, joint secretaries, mission directors, advisors and side entrants.